GLP-1 Medications, Ozempic & Fertility: What to Know

If you are dealing with PCOS, insulin resistance, weight that will not budge, or irregular cycles, you have probably heard about GLP-1 medications. Ozempic. Wegovy. Maybe Mounjaro. They are all over the news, all over social media, and increasingly common in the waiting room. And one question keeps coming up: could one of these medications help me get pregnant?

It is a fair question, and an important one. Below is an honest, thorough look at where GLP-1 medications fit, and where they do not fit, in a fertility journey, based on the current prescribing guidance and the research available as of 2026.

What are GLP-1 medications, and why is everyone talking about them?

GLP-1 stands for glucagon-like peptide-1. These are receptor agonist medications, which means they mimic a hormone your gut naturally releases when you eat. That hormone signals your pancreas to release insulin, tells your brain you are full, and slows how quickly your stomach empties. The result is that many people eat less, their blood sugar stabilizes, and over time they lose a meaningful amount of weight.

Semaglutide is the active ingredient in both Ozempic and Wegovy. Ozempic is approved for type 2 diabetes management, and Wegovy is approved for weight management. Mounjaro (tirzepatide) works on a similar but slightly different mechanism. These medications have been genuinely helpful for many people, and in some cases that weight loss has had positive downstream effects on hormones and cycles.

Here is the part that matters most for fertility, though. These medications were not designed for people who are actively trying to conceive, and they were not studied in that population. The labeling for semaglutide advises stopping the medication at least 2 months before a planned pregnancy, largely because of how long it stays in the body.

What to keep in mind: the useful question is not whether Ozempic is simply good or bad. The better question is how the metabolic improvements these medications support connect to your fertility, and what the right approach is if metabolic health is at the root of your challenges.

When can GLP-1 medications actually improve fertility?

For some women, being on a GLP-1 medication can help restore ovulation, and there is research behind that connection. The link runs through insulin resistance, which is one of the most underdiagnosed drivers of fertility challenges, especially in women with PCOS.

When your cells stop responding well to insulin, your pancreas produces more and more of it. Those chronically elevated insulin levels signal the ovaries to produce more androgens such as testosterone, and elevated androgens are a big part of why ovulation becomes irregular or stops. By reducing insulin resistance and supporting weight loss, GLP-1 medications can lower circulating insulin, which in turn can reduce androgen production and allow ovulation to return.

A meta-analysis of GLP-1 use in women with PCOS reported improvements in menstrual regularity, metabolic markers, and pregnancy rates. In clinical practice, this pattern is common: when the metabolic picture improves, the reproductive picture often follows.

One Hope Fertility Program member had been told for years that her challenges were mostly about her weight. She had PCOS, thyroid dysfunction, and recurring losses, yet the conversation always circled back to weight. When we addressed the root issues together, the insulin resistance, the thyroid function, and the inflammation, her cycles regulated, her ovulation improved, and she was able to get pregnant. It was not magic. It was understanding what was actually driving the problem.

What to do instead of guessing: think of a GLP-1 as a possible tool for the preparation phase, not the trying-to-conceive phase, and not pregnancy. That distinction matters enormously, and it should be discussed with your prescribing physician as part of a full plan.

Why are GLP-1 medications not recommended while you are actively trying to conceive?

This is where a lot of confusion shows up online, so let us be clear. The prescribing labels for semaglutide (Ozempic and Wegovy) advise stopping the medication at least 2 months before a planned pregnancy. That washout period reflects the fact that semaglutide has a long half-life and takes time to clear the body.

What about accidental exposure? The most reassuring data so far comes from a multicentre observational cohort study published in BMJ Open in 2024, which looked at outcomes in women inadvertently exposed to GLP-1 medications in early pregnancy. Compared with reference groups, the study did not find a significantly increased risk of major birth defects or pregnancy loss.

That is genuinely reassuring, but it is not a green light to stay on these medications once you know you are pregnant. Sample sizes remain limited, and the researchers were clear that larger studies are needed and that current guidance to stop the medication remains in place.

What to do instead: if you are on a GLP-1 right now and you are actively trying to conceive, talk with your prescribing physician about transitioning off, give your body the full washout window, and make sure you have a plan for what happens next. That next part is where things get tricky.

What happens when you stop a GLP-1, and why does it matter for pregnancy?

This is the part of the conversation most people are not having, and it may be one of the most important fertility implications of GLP-1 use. When you stop a GLP-1 medication, especially after being on it for a while, appetite often returns, sometimes intensely. Weight can come back quickly, and with the weight often comes the return of insulin resistance and the hormonal disruption that goes with it.

Emerging observational research reported in 2025 looked at women who discontinued GLP-1 medications before or early in pregnancy and pointed to higher average weight gain during pregnancy, along with higher rates of gestational diabetes, preterm delivery, and hypertensive disorders of pregnancy compared with similar women. This is observational data, so it cannot prove cause and effect, but the biological logic is reasonable.

Consider how it fits together. GLP-1 medications suppress appetite and reduce insulin resistance. Stopping them can mean a rapid return of appetite and worsening insulin sensitivity. Pregnancy itself is a naturally insulin-resistant state. For some women, that combination of metabolic rebound plus the metabolic demands of pregnancy can create a difficult situation.

What to do instead: the goal is not only to get pregnant. The goal is to get your body genuinely ready for pregnancy. A strong metabolic foundation, rather than the temporary suppression of symptoms by a medication, is what tends to serve you and your pregnancy best. When the underlying drivers are addressed systematically, you are far less dependent on a medication to maintain the improvement, because your physiology has actually shifted.

What should you do instead: addressing the root cause metabolically

If GLP-1 medications are not the answer for the actively trying-to-conceive phase, what is? First, an honest point: if you have significant insulin resistance, excess weight, or PCOS, these are real, addressable fertility factors. They are not things to ignore or push through, and they are not things that only medication can address. Here is the framework used with Hope Fertility Program members, whether or not someone has been on a GLP-1.

1. Regulate blood sugar through diet. This does not mean a restrictive, miserable diet. It means a strategic eating pattern that keeps insulin stable throughout the day: prioritizing protein and healthy fat at every meal, limiting refined carbohydrates and processed foods, and eating in a way that supports steady energy without the spikes and crashes that worsen insulin resistance. One member, after years of being told to just eat less and exercise more, worked on her metabolic picture with a targeted nutrition approach alongside supplementation often used for insulin sensitivity, such as berberine, inositol, and omega-3s. Within a few months her cycles became regular for the first time in years. Individual results vary, and supplements should be reviewed with your provider.

2. Move strategically. Strength training is particularly valuable for insulin resistance, because building muscle improves insulin sensitivity. Even two to three sessions per week can make a meaningful difference in metabolic markers over 90 days.

3. Test properly. This is where functional medicine distinguishes itself from conventional care. Rather than checking fasting glucose alone, a fuller workup can include fasting insulin, HbA1c, a full lipid panel, inflammatory markers, hormonal profiles including androgens, and thyroid function. That fuller picture is not only about diagnosing a problem. It gives you a baseline, so you can measure real change over time: insulin sensitivity improving, androgen levels dropping, and cycles regulating.

The HOPE approach in one sentence

When you assess what is actually driving your metabolic challenges, whether that is insulin resistance, thyroid dysfunction, inflammation, gut health, or adrenal stress, and you address those root causes systematically, your metabolic picture can change, and your fertility picture can change with it.

Frequently asked questions about GLP-1 medications and fertility

Can Ozempic help you get pregnant?

Indirectly, yes, for some women. In women with PCOS and insulin resistance, Ozempic and other GLP-1 medications can lower insulin, reduce excess androgens, and support weight loss, which can help restore ovulation. This is a preparation-phase benefit. The prescribing guidance is to stop semaglutide at least 2 months before actively trying to conceive, so any plan should be made with your prescribing physician.

How long before trying to conceive should you stop a GLP-1 medication?

The prescribing information for semaglutide advises stopping at least 2 months before a planned pregnancy, because the medication has a long half-life and takes time to clear the body. Your physician can confirm the right timing for your specific medication and situation.

Is it dangerous to be on Ozempic or Wegovy during pregnancy?

GLP-1 medications are not recommended during pregnancy. A 2024 BMJ Open cohort study of inadvertent early exposure was reassuring and did not find a significantly increased risk of major birth defects or pregnancy loss, but sample sizes are still limited and the guidance to stop remains in place. If you become pregnant while taking one, contact your prescribing physician promptly.

What happens to fertility and pregnancy when you stop a GLP-1?

Stopping a GLP-1 can bring back appetite and insulin resistance, sometimes quickly. Emerging observational research in 2025 associated discontinuation before or early in pregnancy with more weight gain and higher rates of gestational diabetes and preterm delivery. Because this is observational data it cannot prove cause and effect, but it highlights why building a strong metabolic foundation matters.

Can you improve PCOS and insulin resistance for fertility without medication?

For many women, yes. A strategic approach that combines blood-sugar-stabilizing nutrition, strength-based movement, targeted testing, and, where appropriate, supplementation such as inositol can improve insulin sensitivity and support more regular cycles. Results vary from person to person, and a plan should be built with a qualified provider.

References

• Dao K, et al. Reproductive safety of glucagon-like peptide-1 receptor agonists: a multicentre observational cohort study of inadvertent pregnancy exposure. BMJ Open, 2024.
• Prescribing information for semaglutide (Ozempic, Wegovy), including guidance to discontinue at least 2 months before a planned pregnancy.
• Meta-analyses of GLP-1 receptor agonist use in women with PCOS reporting improvements in menstrual regularity and metabolic markers.
• Emerging observational research (2025) on GLP-1 discontinuation before or early in pregnancy and associations with weight gain, gestational diabetes, and preterm delivery. Findings are observational and do not establish causation.